Michael Pollak, MD, holds the Alexander Goldfarb Research Chair in cancer research at McGill University in Montreal and directs the division of cancer prevention of the Department of Oncology.
He practices medical oncology at the Jewish General Hospital in Montreal and is involved in clinical trials of novel agents related to growth factor targets. He also runs a research lab at the Lady Davis Research Institute, which is affiliated with the hospital and McGill. The laboratory’s research focuses on insulin and IGF physiology in relation to cancer and provides specialized ELISA assays for epidemiologic and pharmaceutical collaborators.
Pollak has published more than 300 research papers and collaborates with leading cancer research groups worldwide in laboratory, clinical, and epidemiologic studies related to the role of growth factors in human cancer. He is co-editor-in-chief of Cancer Prevention Research, an international journal published by the American Association for Cancer Research.
Pollak received both his bachelor’s degree in biology and computer services and his medical degree from McGill University. He is a Fellow of the Canadian Academy of Health Sciences and the Royal College of Physicians and Surgeons of Canada.